美女免费一级视频在线观看

    1. <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      Klick Health announced the winners of its annual Klick Prize competition Thursday evening, honoring a pair of AI-enhanced pharma marketing solutions.

      The 2024 MM+M Agency 100 honoree received hundreds of submissions from its employees during the yearlong effort, all focused on advancing solutions in the healthcare marketing space. 

      Leerom Segal, Klick’s cofounder and chairman, said this year’s competition sought to encourage the agency’s staff to give generative AI a try and have fun experimenting with the innovative tech. The result was a victory for an AI-enhanced pharma marketing compliance tool.

      The $1 million Grand Prize was awarded to a project dubbed “Guardrail,” which automatically analyzes submissions and layers in a client’s compliance posture and history to automate the entire approval workflow for assets. 

      Guardrail helps marketing teams navigate regulatory frameworks in a more efficient manner. Segal said the team has already tested the tool, noting that it has assisted in enhancing asset authoring and review processes. 

      The product, conceived by two members of the Klick Medical team alongside a tech developer and project manager, also won the first round of competition back in May. 

      Meanwhile, second place was awarded to an immersive AI/human interaction platform that simulates AI “agents” to act as patients and healthcare professionals. The aim of the tool is to enhance research and drive user experiences beyond the current basic chatbot exchanges. 

      Among the finalists was a podcast communications tool that creates personalized synthesized messages from meetings, which Segal highlighted as having potential for targeted reach to consumers.

      The entries were reviewed and evaluated by senior executives from blue-chip pharma companies like Bristol Myers Squibb, Pfizer, Sobi and Novartis, among others. 

      Segal said Klick was excited about having executives from large biotech and pharma companies as judges, noting that their guidance helped select ideas that are actually useful and relevant to the industry. The judges not only selected the winners, but also allocated the award funds accordingly. 

      Beyond the competition, Segal said Klick is supporting the development, testing and reiterations of the submitted ideas. 

      “The Klick prizes that were awarded this year are platforms in production,” he said. “We’re doing pilots with active clients. These are not just ideas — they’re now new lines of business for Klick.” 

      Additionally, Klick has specific goals in mind for its new product ideas and has set targets for their use within the company. 

      “Our expectation is that by the end of 2025, 100% of our workflows for content creation will be augmented with Guardrail, essentially helping us drive higher quality and faster time to market,” he said. 

      Over the last few years, the agency has emphasized AI as part of its product development. The team has unveiled several AI-interaction technology products to improve communications and research in the industry. 

      Klick also launched an AI model that detects type 2 diabetes using 10 seconds of voice as well as KCM+AI, an AI social media comment moderator for the life sciences industry and LOVENet, an AI framework that identifies new uses for existing drugs on the market. 

      When it comes to the development of new products and tools, Segal said what Klick prioritizes always ties back to the firm’s values. 

      “The ultimate goal is always achieving high impact work,” he said.